Phillip P. Chan - Jul 7, 2023 Form 4 Insider Report for Cytosorbents Corp (CTSO)

Role
Chief Executive Officer, Director
Signature
/s/ Kathleen P. Bloch attorney-in-fact for Phillip P. Chan
Stock symbol
CTSO
Transactions as of
Jul 7, 2023
Transactions value $
$0
Form type
4
Date filed
7/11/2023, 08:31 PM
Previous filing
Apr 5, 2023
Next filing
Dec 15, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CTSO Common Stock Award $0 +87K +9.46% $0.00 1.01M Jul 7, 2023 Direct F1, F2, F3, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CTSO Stock Option (right to buy) Award $0 -112K -50% $0.00 112K Jul 7, 2023 Common Stock 112K $3.53 Direct F5
transaction CTSO Stock Option (right to buy) Award $0 -48K -50% $0.00 48K Jul 7, 2023 Common Stock 48K $3.53 Direct F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares represent restricted stock units ("RSUs") which shall vest as to two-thirds of the award on the first anniversary of the date of grant and one-third of the award on the second anniversary of the date of grant, subject to the reporting person's continued service as of the applicable vesting date.
F2 Includes (a) the following RSUs that will be settled into shares of the Issuer's Common Stock upon vesting upon a "Change In Control" of the Issuer as defined in the Amended and Restated CytoSorbents Corporation 2014 Long-Term Incentive Plan (the "Plan"): (a) 10,300 RSUs granted on March 15, 2018, (b) 18,700 RSUs granted on February 24, 2017, (c) 57,000 RSUs granted on June 7, 2016 and (d) 130,000 RSUs granted on April 8, 2015;
F3 (continued from footnote 2) (b) the following RSUs: (i) 52,667 RSUs granted on August 10, 2022 and unvested as of the date hereof (which vest as to one-third of the award on each of the date of grant, the first anniversary of the date of grant, and the second anniversary of the date of grant, subject to the reporting person's continued service as of the applicable vesting date) and (ii) 87,000 RSUs granted on July 7, 2023 and reported on this Form 4; and
F4 (continued from footnote 3) (c) 650,881 shares of the Issuer's common stock owned by the reporting person.
F5 These stock options were granted pursuant to the Plan. The shares underlying these stock options vest as to one-half of the award on the first anniversary of the date of grant, one-fourth of the award on the second anniversary of the date of grant, and onefourth of the award on the third anniversary of the date of grant, subject to the reporting person's continued service as of the applicable vesting date.
F6 These stock options were granted pursuant to the Plan. The shares underlying these stock options vest as to one-half of the award on each of the first anniversary of the date of grant and the second anniversary of the date of grant, subject to the reporting person's continued service as of the applicable vesting date.